Sodium in PDB 6yhj: Thrombin in Complex with D-Phe-Pro-2-Chlorothiophen Derivative (16E)
Enzymatic activity of Thrombin in Complex with D-Phe-Pro-2-Chlorothiophen Derivative (16E)
All present enzymatic activity of Thrombin in Complex with D-Phe-Pro-2-Chlorothiophen Derivative (16E):
3.4.21.5;
Protein crystallography data
The structure of Thrombin in Complex with D-Phe-Pro-2-Chlorothiophen Derivative (16E), PDB code: 6yhj
was solved by
A.Sandner,
A.Heine,
G.Klebe,
C.Collins,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.53 /
1.44
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
70.285,
71.399,
72.56,
90,
100.58,
90
|
R / Rfree (%)
|
12.7 /
15.4
|
Other elements in 6yhj:
The structure of Thrombin in Complex with D-Phe-Pro-2-Chlorothiophen Derivative (16E) also contains other interesting chemical elements:
Sodium Binding Sites:
The binding sites of Sodium atom in the Thrombin in Complex with D-Phe-Pro-2-Chlorothiophen Derivative (16E)
(pdb code 6yhj). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 2 binding sites of Sodium where determined in the
Thrombin in Complex with D-Phe-Pro-2-Chlorothiophen Derivative (16E), PDB code: 6yhj:
Jump to Sodium binding site number:
1;
2;
Sodium binding site 1 out
of 2 in 6yhj
Go back to
Sodium Binding Sites List in 6yhj
Sodium binding site 1 out
of 2 in the Thrombin in Complex with D-Phe-Pro-2-Chlorothiophen Derivative (16E)
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Thrombin in Complex with D-Phe-Pro-2-Chlorothiophen Derivative (16E) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
H:Na301
b:18.4
occ:1.00
|
O
|
H:HOH579
|
2.3
|
20.9
|
1.0
|
O
|
H:ARG221A
|
2.3
|
20.4
|
1.0
|
O
|
H:LYS224
|
2.4
|
15.1
|
0.4
|
O
|
H:LYS224
|
2.4
|
15.0
|
0.6
|
O
|
H:HOH478
|
2.4
|
18.6
|
1.0
|
O
|
H:HOH471
|
2.5
|
16.5
|
1.0
|
O
|
H:HOH485
|
2.8
|
23.2
|
1.0
|
H
|
H:LYS224
|
3.2
|
20.7
|
0.4
|
H
|
H:LYS224
|
3.3
|
20.8
|
0.6
|
C
|
H:ARG221A
|
3.4
|
20.5
|
1.0
|
C
|
H:LYS224
|
3.4
|
15.1
|
0.4
|
C
|
H:LYS224
|
3.4
|
15.0
|
0.6
|
HA
|
H:ASP221
|
3.7
|
23.5
|
1.0
|
HA
|
H:ASP222
|
3.8
|
27.9
|
1.0
|
HB2
|
H:LYS224
|
3.8
|
20.9
|
0.6
|
O
|
H:HOH529
|
3.8
|
17.4
|
1.0
|
HB2
|
H:LYS224
|
3.8
|
20.3
|
0.4
|
N
|
H:LYS224
|
3.9
|
17.2
|
0.4
|
N
|
H:ARG221A
|
3.9
|
20.6
|
1.0
|
N
|
H:LYS224
|
3.9
|
17.3
|
0.6
|
H
|
H:ARG221A
|
3.9
|
24.8
|
1.0
|
H
|
H:GLY223
|
4.0
|
26.1
|
1.0
|
HA
|
H:TYR225
|
4.0
|
16.2
|
1.0
|
O
|
H:HOH464
|
4.0
|
23.7
|
1.0
|
C
|
H:ASP221
|
4.1
|
20.4
|
1.0
|
O
|
H:TYR184A
|
4.1
|
18.9
|
1.0
|
CA
|
H:LYS224
|
4.1
|
16.8
|
0.6
|
CA
|
H:LYS224
|
4.1
|
16.5
|
0.4
|
N
|
H:ASP222
|
4.2
|
21.9
|
1.0
|
CA
|
H:ARG221A
|
4.2
|
21.0
|
1.0
|
O
|
H:HOH495
|
4.3
|
17.5
|
1.0
|
N
|
H:GLY223
|
4.3
|
21.8
|
1.0
|
CA
|
H:ASP222
|
4.3
|
23.3
|
1.0
|
CA
|
H:ASP221
|
4.4
|
19.6
|
1.0
|
N
|
H:TYR225
|
4.4
|
14.5
|
1.0
|
CB
|
H:LYS224
|
4.5
|
17.4
|
0.6
|
CB
|
H:LYS224
|
4.5
|
16.9
|
0.4
|
O
|
H:ASP221
|
4.5
|
21.8
|
1.0
|
C
|
H:ASP222
|
4.6
|
22.7
|
1.0
|
OD1
|
H:ASP221
|
4.6
|
20.4
|
1.0
|
CA
|
H:TYR225
|
4.7
|
13.5
|
1.0
|
HB2
|
H:ARG221A
|
4.8
|
26.7
|
1.0
|
C
|
H:GLY223
|
4.9
|
18.1
|
1.0
|
HB3
|
H:LYS224
|
4.9
|
20.9
|
0.6
|
O
|
H:HOH541
|
4.9
|
20.3
|
1.0
|
H
|
H:ASP221
|
4.9
|
22.4
|
1.0
|
HB2
|
H:ASP189
|
4.9
|
19.0
|
1.0
|
HA
|
H:ARG221A
|
5.0
|
25.2
|
1.0
|
HA3
|
H:GLY184
|
5.0
|
14.6
|
1.0
|
|
Sodium binding site 2 out
of 2 in 6yhj
Go back to
Sodium Binding Sites List in 6yhj
Sodium binding site 2 out
of 2 in the Thrombin in Complex with D-Phe-Pro-2-Chlorothiophen Derivative (16E)
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Thrombin in Complex with D-Phe-Pro-2-Chlorothiophen Derivative (16E) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
H:Na302
b:13.9
occ:1.00
|
O
|
H:THR172
|
2.3
|
14.2
|
1.0
|
O
|
H:LYS169
|
2.4
|
14.3
|
0.4
|
O
|
H:HOH525
|
2.4
|
31.5
|
1.0
|
O
|
H:LYS169
|
2.4
|
14.2
|
0.6
|
O
|
H:HOH605
|
2.4
|
16.7
|
1.0
|
O
|
H:HOH502
|
2.8
|
22.5
|
1.0
|
HA
|
H:ASP170
|
3.3
|
17.2
|
1.0
|
HG2
|
H:LYS169
|
3.4
|
25.2
|
0.6
|
C
|
H:LYS169
|
3.5
|
14.3
|
0.4
|
C
|
H:LYS169
|
3.5
|
14.1
|
0.6
|
H
|
H:THR172
|
3.5
|
17.4
|
1.0
|
HG2
|
H:LYS169
|
3.5
|
22.8
|
0.4
|
C
|
H:THR172
|
3.6
|
13.8
|
1.0
|
HA
|
H:ARG173
|
3.6
|
17.6
|
1.0
|
HZ3
|
H:LYS169
|
3.8
|
29.4
|
0.4
|
CA
|
H:ASP170
|
4.0
|
14.3
|
1.0
|
HG3
|
H:LYS169
|
4.1
|
25.2
|
0.6
|
N
|
H:ASP170
|
4.2
|
14.0
|
1.0
|
CG
|
H:LYS169
|
4.2
|
21.0
|
0.6
|
N
|
H:THR172
|
4.3
|
14.5
|
1.0
|
HG3
|
H:LYS169
|
4.3
|
22.8
|
0.4
|
CG
|
H:LYS169
|
4.3
|
19.0
|
0.4
|
HG23
|
H:THR172
|
4.4
|
19.1
|
1.0
|
C
|
H:ASP170
|
4.4
|
14.7
|
1.0
|
CA
|
H:ARG173
|
4.4
|
14.6
|
1.0
|
N
|
H:ARG173
|
4.4
|
14.0
|
1.0
|
HA
|
H:LYS169
|
4.5
|
17.4
|
0.4
|
HA
|
H:LYS169
|
4.5
|
17.2
|
0.6
|
CA
|
H:LYS169
|
4.6
|
14.3
|
0.6
|
O
|
H:HOH424
|
4.6
|
38.3
|
1.0
|
CA
|
H:THR172
|
4.6
|
14.2
|
1.0
|
CA
|
H:LYS169
|
4.6
|
14.5
|
0.4
|
HG22
|
H:THR172
|
4.6
|
19.1
|
1.0
|
HE2
|
H:LYS169
|
4.6
|
30.9
|
0.6
|
NZ
|
H:LYS169
|
4.7
|
24.5
|
0.4
|
O
|
H:ASP170
|
4.7
|
14.4
|
1.0
|
OD1
|
H:ASP170
|
4.8
|
18.0
|
1.0
|
N
|
H:SER171
|
4.8
|
13.3
|
1.0
|
HZ2
|
H:LYS169
|
4.9
|
29.4
|
0.4
|
CG2
|
H:THR172
|
4.9
|
15.9
|
1.0
|
HE3
|
H:LYS169
|
4.9
|
30.9
|
0.6
|
H
|
H:SER171
|
4.9
|
16.0
|
1.0
|
CB
|
H:LYS169
|
4.9
|
17.1
|
0.6
|
CB
|
H:LYS169
|
5.0
|
16.5
|
0.4
|
|
Reference:
A.Sandner,
A.Heine,
G.Klebe.
Thrombin in Complex with D-Phe-Pro-2-Chlorothiophen Derivative (16E) To Be Published.
Page generated: Tue Oct 8 15:08:00 2024
|